Literature DB >> 25287596

Multiple sclerosis: Blood-based biomarkers provide insight into progressive MS.

Hemi Malkki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25287596     DOI： 10.1038/nrneurol.2014.189

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  2 in total

1.  Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.

Authors:  Amanda K Huber; Lu Wang; Peisong Han; Xu Zhang; Sven Ekholm; Ashok Srinivasan; David N Irani; Benjamin M Segal
Journal:  Neurology       Date:  2014-09-24       Impact factor: 9.910

2.  A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.

Authors:  Alex M Dickens; James R Larkin; Julian L Griffin; Ana Cavey; Lucy Matthews; Martin R Turner; Gordon K Wilcock; Benjamin G Davis; Timothy D W Claridge; Jacqueline Palace; Daniel C Anthony; Nicola R Sibson
Journal:  Neurology       Date:  2014-09-24       Impact factor: 9.910
  2 in total
  1 in total

1.  An Integrated Bioinformatics Analysis of the Potential Regulatory Effects of miR-21 on T-cell Related Target Genes in Multiple Sclerosis.

Authors:  Mostafa Manian; Ehsan Sohrabi; Nahid Eskandari; Mohammad-Ali Assarehzadegan; Gordon A Ferns; Mitra Nourbakhsh; Mir Hadi Jazayeri; Reza Nedaeinia
Journal:  Avicenna J Med Biotechnol       Date:  2021 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.